We thank the Scientific Computing and Imaging Institute of the University of Utah for use of FluoRender software (R01GM09815). This work was supported by grants from the Glaucoma Research Foundation, Melsa M. and Frank Theodore Barr Foundation and the US National Institute of Health, (R01EY020878 and R01EY023621) to M.L.V., and (R01EY017182 and R01EY017950) to B.K.A.

在活体成像使用犹他州大学批准的机构动物护理和使用委员会协议无致病菌设施进行。 注意：此成像协议用于报告小鼠中视网膜小胶质细胞和浸润的单核细胞/巨噬细胞表达的fractalkine的受体基因座（CX3CR1）的控制下，绿色荧光蛋白（GFP）。 1. 在视网膜GFP +小胶质细胞的体内成像共聚焦扫描激光眼底镜检查（CSLO） <ol><li>转水控制的加热系统，建立稳定过程中，35〜37ºC鼠标之间的温度，并连接两个加热垫。 <ol><li>启动共焦扫描激光检眼镜（CSLO）系统（ 图2A）。打开CSLO程序，输入，将确定个人鼠标设置为2毫米（患者数据菜单）角膜曲率的信息。 </li></ol></li><li>准备IMA更改。安全地装配在其插槽干净55º宽视场物镜。通过确保加热垫铺上干净的纸准备眼底成像平台。使用夹子拼合垫和纸张，并保持他们从挡住物镜的移动。 </li><li>通过腹膜内注射1.3％2,2,2-三溴乙醇和0.8％的叔戊醇麻醉小鼠（250毫克/千克体重;0.5毫升/ 25克体重），使用30½ģ针装到1毫升的一次性注射器。返回鼠标笼子里，不停地在一个加热垫。 注：在麻醉注射与吸入的交付使鼠标成像和通畅的进入眼中，免费的鼻锥体和管更容易定位。 </li><li>一旦动物会不动，是没有响应于尾捏，诱导瞳孔扩大与托品和苯（各0.5％），通过定位动物俯卧和覆盖双眼用的液滴7分钟。 </li><li> 5分钟后，对花边鼠标俯卧在眼底平台的中心，适合隐形眼镜了双眼，将最小的压力。 注：隐形眼镜小且脆弱，但可以用手指小心处理，虽然镊子可以用来代替40。使用隐形眼镜是可选的，但是推荐，因为它最大限度地减少眼干涩和成像过程中保持角膜透明。 </li><li> 7分钟后，定位鼠标与右眼面对物镜和平行于物镜的轨道，保持无节制的平台（ 图2B）的边缘附近的动物。收集可比饱和度和取向的图像，不断维持从眼睛到物镜的距离，以及眼睛的对准的光路整个成像会话。剪贴长须与观察眼睛的干扰。 注：在接下来的8-10分钟，鼠标不移动或闪烁，并会呼吸，轻轻动ments，这是由CSLO眼睛跟踪技术（自动实时）模式，其调节基于眼底标具有高对比度的扫描头的位置进行跟踪。过去的那个时候，老鼠开始喘气和眨眼，使成像不切实际的。 </li><li>如果不使用隐形眼镜进行成像，应用PBS下降到双眼每隔2-3分钟，以防止它们干燥。 </li><li>收集的视网膜血管和视盘的眼底图像，聚焦在视网膜内层。 <ol><li>选择红外模式（IR）和调整设置到820纳米的激发，100％的激光功率，40-60％的敏感性（ 图2C）。 </li><li>工作在高速模式（12.6帧/秒），使用操纵杆来驱动眼底镜定位眼球。在低放大倍数，检查角膜和晶状体用于损伤或不透明，并且从研究眼睛排除具有缺陷或损伤，将影响成像的视网膜（ 图3A）。 </li><li>定位视盘区域（表面视神经乳头，ONH）通过使目标更接近眼球，然后居中在图像上，并通过拧操纵杆锁定这个位置。眼睛的眼底的这种对齐是关键，甚至获得整个图像聚焦和发射。 </li><li>可视化的视网膜的内面，以及视盘，使用位于在视网膜上作为参考焦平面（59和60 D）中，或更深（55 D）的玻璃体表面上的主要血管中的眼睛表示挖掘视神经光盘。最佳的重点应该在解决主要血管循环血细胞，用自己的管腔和墙壁明显不同。 </li><li>优化图像饱和度调节触摸屏控制面板上的旋钮，直到均匀照明的白色光晕在大多数视盘周围的55º眼底场的跨越（使用轻微过曝）。接着，降低饱和度，以优化对比度直到血细胞沿大血管运动可以清楚地分辨。如果震源深区坚持，不能因视网膜损伤，重新调整眼相机获得均匀明亮的图像，直到。这种调整是根本捕捉重现的图像集的位置和质量。 </li><li>收集中心视网膜的高分辨率红外图像（1.4-1.7毫米直径，这取决于年龄），平均实时30帧（4.7帧/秒;归一化），以提高信噪比（ 图2D ）。 </li></ol></li><li>立即，获得的GFP +小胶质细胞和/或局部视网膜和视盘的内面浸润的单核细胞的荧光图像。 注：视网膜的红外眼底图像的优化确定的GFP +细胞的荧光图像的分辨率，以及内层视网膜的程度跨越。未能集中在视网膜上，其可通过脉管系统的分辨率差被检测的内面，将导致在调暗的GFP +细胞视图（ 图3B）。未能调整IR凡城配给正确且均匀地影响荧光图像（FA），引入在GFP +细胞的强度和大小（ 图3C）人为的变化。 <ol><li> SWICH至荧光成像模式（FA）中的触摸屏面板，使用蓝色，488 nm激光激发（460-490毫微米阻挡滤波器集合），并采集设置（100％的激光功率和100-125％的灵敏度），其被保持常数所有小鼠（ 图2E）。 </li><li>收集单一的XY点，视网膜的二维荧光图像，并立即在同一位置拍摄眼底图像（100倍的扫描平均水平; 55°扫描角度为两个图像; 图2F）。 </li><li>通过在控制面板（ 图2G）选择“复合”和移动眼底镜左，右，平移整个鼻时间轴（ 图2H）视网膜捕获图像多。 注：扫描单XY-点图像后（100X s可以平均值），该软件自动实时平均值相同，新领域（外有绿色圆圈新的扫描过程中最佳的扫描，或当扫描不可行红色），和所有的针XY-位置。所得到的复合图像跨越1.5-1.7毫米的水平轴x 3-4毫米，在垂直轴（55°x120-124º扫描角）。 </li></ol></li><li>每只小鼠在15分钟内诱导麻醉，闪烁，运动前重新启动完成后成像。 </li><li>取下隐形眼镜，眼睛水合物用PBS和动物返回到其回暖笼子，检查行为，直到蠕动完全恢复。 </li><li>对于采用间歇CSLO成像会话在同一个体小鼠的纵向研究，重复成像不少于3天开以避免麻醉的蓄积毒性，以及角膜刺激。 </li></ol> 2.实时图像处理和分析<ol><li>连续的图像对齐： <ol><li>对齐眼底图像用血管和视盘作为​​路标的时间序列相同的眼球。在商业幻灯片放映演示程序，通过拖动每幅图像比前一个，直到他们视盘对准在XY-平面（顶部图像出现半透明的同时拖动），然后旋转顶部图像，直到所有打开的图像主要血管重叠下面（集中在船只最远从视盘）的图像上的血管。记录每个图像的旋转角度和保存这个时间序列以供将来参考，跟踪鼠标和眼睛的身份。 </li><li>通过将记录角度来校正在每个时间点在xy旋转，使用一个光栅图形编辑程序对准相应系列的单的xy点的荧光图像。此外，调整分辨率为300 dpi（不缩放）和背景（在RGB模式下，选择级别和品尝血管黑色的流明）。保存这些图片为TIF文件，加入“结盟”到他们的名字。 </li></ol></li><li>胶质细胞分割： <ol><li>以确定的GFP +细胞在中心视网膜，在FluoRender开放对应于最早的时间点/年龄的“对准”的TIF文件。缩放图像以适应屏幕，然后定义渲染视图（复合材料，正交，插值）及其属性（0.58伽玛，饱和度255点，255的亮度，195α和1.00色带所示），同时选择了RG渠道可见（隐藏双击它，在工作区框架B通道; 图4A）。 </li><li>选择单个细胞，阈红色通道（必须在工作空间框架中突出显示），通过增加低阈值，直到大部分细胞被屏蔽（白色）与最小的重叠和细胞过程（青色），同时保持高的阈值恒定（255）。介于100和170中的低阈值而变化，这取决于荧光强度（ 图4B &lt;/ STRONG&gt;）。 </li><li>保存这一观点与红色通道仅可见（捕获命令）作为一种新的TIF文件，添加“cellsegm”到原来的名称（ 图4C）。使用通用光栅图形编辑软件，它的反转灰阶调整分辨率为300 dpi的上面，并重新保存为RGB（ 图4D）。 注意：删除文件夹（项目）由FluoRender自动创建，并保存备查应用门槛。 </li></ol></li><li>小胶质细胞胞体分割和形态： <ol><li>以确定的GFP +细胞胞体为区域量化，使用图像分析软件以自动强度测量和阈值的功能，以及基于阈值的对象计数和测量。打开“cellsegm”TIF文件，并​​选择重调方法（样条）和红色通道（点击RGB红色标签）。通过取消选择“彩色视图通道”提高可视化（右键单击红色的RG乙标签），并选择“补色”（图像/调整图像）反转灰阶，看到了细胞的灰色/黑色在白色背景（ 图4E）。 </li><li>校准图像以1.4-1.7毫米取决于年龄，通过绘制一条水平线整个图像（校准，连结校准）。 </li><li>段个别细胞胞体通过施加强度阈值（ 图4B）。对于这一点，在红色的RGB通道的工作，并打开阈强度函数（对象计数;选择“计数更新”命令），以便跟踪二维参数的感兴趣区域（ROI），每个阈值区域表示各个胞体。 </li><li>限定在所述强度直方图的亮度临界值，通过选择255层次的最低50-60％，并通过目视评价阈颜色掩模（蓝色）和胞体周长（灰色）之间的重叠精炼最终阈值单个细胞（Figure 4E）。 </li><li>估计胞体掩模的精度来代表常染色体的尺寸由前测量区和后分割在10个细胞，并接受所选择的阈值范围内，如果测量相差低于10％（使用的二元工具栏和注释测量值）。 </li><li>手动识别常染色体的ROI包括多个细胞，并分离这些元件（消除或分开的ROI使用二元工具栏的控制，或在对象目录）而切换接通/断开的二值直接可视化的细胞（ 图4F）。 </li><li>分类小神经胶质细胞为感兴趣区与常染色体区域且小于50-60微米2以鉴别细胞胞体对应于激活的小胶质细胞和分别停用小胶质细胞，通过使用区域限制。 注意：每个细胞常染色体子集被标识与不同的伪彩色二进制层，并且可以进一步表征为其它形态参数（PERIME之三，圆等 ），以及离散的视网膜扇区（ 图4G）内量化。所分析的图像保存为一个文件ND2。 </li><li>验证过程和分支的复杂性在个别激活小神经胶质细胞，通过覆盖在面膜常染色体和单XY -点图像（对比度提高了50％; 图4H）。手动计数从细胞胞体直接延伸的处理或测量多边形包围心轴（使用二元工具栏和注释测量值）的直径。 注：活性细胞缺乏过程或承受几（&lt;4）和短（&lt;2×常染色体直径）的人，而相比之下，非活化细胞过程，其包括一个网状和广泛乔木（&gt; 3 - 10倍常染色体直径）周围的相对小胞体。 </li><li>手动识别细胞胞体小于&lt;20微米2和/或GFP表达低于检测极限，因此这是由在未被发现张力阈值。在使用的注解命令分类计数人工识别元素。 </li></ol></li></ol>

The authors have nothing to disclose.

神经变性疾病中在线监测的小胶质细胞数目和形态的激活需要使用的非侵入性的成像方法，使细胞的功能的详细可视化。成像后，小胶质细胞，必须分离（分段），用于形态测定分析通过使用多个阈值的步骤，以评估常染色体的大小和/或过程的复杂性作为读数为小胶质细胞活化。在这个协议中，我们描述了使用CSLO实时图像采集，和小胶质细胞活化的基于序列的细胞和胞体分割的定量分析方法。?...

小胶质细胞是自早期胚胎发育和整个成年期，专门驻留在中枢神经系统（CNS）神经免疫细胞。配备有受体的复杂剧目，小胶质细胞的活性和区域的异质性是由他们的双向相互作用调节与相邻的神经元，神经胶质细胞，血-脑屏障和渗透神经炎性细胞1,2-。小胶质细胞基础功能有助于生理保养和维修，因为他们品尝其领土的动态平衡3,4扰动。在中枢神经系统损伤或疾病，小胶质细胞是第一个响应者的神经信号，然后触发他们过渡到无功表型，被称为“激活小神经胶质细胞2,5-7。小胶质细胞活化涉及基因和蛋白的表达，其耦合到细胞胞体和过程调整大小和重塑6-9的一个复杂的循环。小胶质细胞的活化，以及细胞和再分配聚类，可伴随在细胞的数量（称为小神经胶质细胞）的本地整体增加。这可能是由于细胞增殖和自我更新，有或没有招募的血液衍生的单核细胞3,4,7,10-14。在范围广泛的年龄依赖性，慢性CNS疾病，持续小神经胶质细胞和小胶质细胞活化平行疾病进展15-19。小胶质细胞是如何影响神经退行性疾病仍不清楚，主要是因为他们玩，可能有疾病发生，发展多样化的贡献都神经保护和有害的作用。实时成像旨在了解的慢性CNS疾病监测了动物模型和人类的受损中枢神经系统的小神经胶质的行为，并证明了小胶质细胞的改变是可检测的开始在早期疾病阶段15-17,19,20。因此，关键是要开发的方法来检测和监测体内小胶质细胞活化。 无创DETE在脑小胶质细胞激活区域变化ction确立为在神经变性疾病的进展体内指示器的重要，使用分子成像或生物发光和正电子发射断层扫描或磁共振成像18,21,22。这些高度量化和非侵入性的分子和核成像方法检测胶质细胞增生与区域分辨率。或者，在CX3CR1 GFP / +小鼠的双光子共焦成像已经允许大脑胶质细胞的观察与细胞分辨率3,4,9,20,23-28。然而，这种方法限制了长期和反复观察慢性小胶质改建，由下式给出甚至微创脑成像程序29干扰它们的行为的潜在风险。或者，视网膜提供了直接的最佳条件， 在体内的可视化和小胶质细胞在其完整的CNS利基整个老化重复监控，急性损伤，并潜在期间慢性神经变性疾病。因此，最近的研究证明了视网膜小胶质细胞表达GFP的高分辨率成像的可行性，通过调整共焦激光扫描眼底镜（CSLO）图像实时CX3CR1 GFP / +小鼠。这已被用于跟踪在个体小鼠长达10周的GFP +细胞数每周改变以下急性诱发损伤或高眼压30-36。 我们已经扩展这种方法来进行长期的成像历时数月，并定量跟踪的基础上利用形态分析胞体大小小胶质细胞活化的变化。常染色体的大小被定义为小胶质细胞活化在实时成像研究使用皮质切片双光子激光共聚焦显微镜 CX3CR1-GFP +小胶质9 体内成像执行有用的指标。这些和其他的研究也证实常染色体大小和Iba1蛋白表达水平之间的相关性，的wh脑出血也随着活化9,37。因此，活化的小胶质细胞可在活体小鼠来鉴定，并且它们的数量和分配过程中的CNS健康和疾病随时间监测。 这个协议描述为CSLO实时图像采集和分析方法，监测小胶质细胞的数量，视网膜神经节细胞（RGC）变性（ 图1）中的分布和形态的活化。因此，本研究的用途：1）遗传性青光眼（DBA / 2J），该发生年龄依赖性视神经和视网膜神经变性和小鼠模型显示5和10个月38,39年龄之间显着的可变性疾病进展，2）每月CSLO 体内成像的GFP +细胞在视网膜长期可视化和杂CX3CR1 GFP / + DBA / 2J小鼠的年龄3-5个月，3）由分段和阈值实时成像分析以分离细胞胞体和测量无髓鞘视神经该IR区。施加这些策略在慢性青光眼的早期阶段，以评估视网膜小胶质细胞激活状态的动力学。

<table border="0" cellpadding="0" cellspacing="0" width="2010">
	<tbody>
		<tr height="21">
			<td height="21" style="height:21px;width:617px;">Name</td>
			<td style="width:444px;">Company</td>
			<td style="width:208px;">Catalog Number</td>
			<td style="width:741px;">Comments</td>
		</tr>
		<tr height="60">
			<td height="60" style="height:60px;width:617px;">DBA/2J and 
			CX3CR1-GFP/+ mice</td>
			<td>The Jackson Laboratory, Bar Harbor, ME</td>
			<td>000671 and 00582</td>
			<td>Mice are breed in-house, introducing new breeders every 3 to 4 generations to prevent genetic drift.</td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">301/2G needle and 1 ml tuberculin slip-tip syringe</td>
			<td>BD, East Rutherford, NJ</td>
			<td>305106 and 309659</td>
			<td></td>
		</tr>
		<tr height="40">
			<td height="40" style="height:40px;width:617px;">2,2,2-tribromoethanol, tert-Amyl alcohol 99% and phosphate buffer saline tablets</td>
			<td>Sigma-Aldrich, St. Louis, MO</td>
			<td>T48402, 152463 and P4417</td>
			<td>Avertin solution (pH 7.3, sterile filtered) must be freshly made solution or stored at 4&#186;C for up to 1 week.</td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">Heat therapy T/Pump</td>
			<td>Gaymar Industries, Orchard Park, NY</td>
			<td>TP-650</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">Cotton-tipped applicators</td>
			<td>Fisher Scientific, Pittsburgh, PA</td>
			<td>23-400-100</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">Tropicamide 1%&#160;</td>
			<td>Bausch &#38; Lomb, Rochester, NY</td>
			<td>NDC 24208-585-64</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">PMMA contact lenses, 1.70-base curve, 3.2 mm total diameter, 0.40 mm-thick center</td>
			<td>Cantor &#38; Nissel Ltd., Northamptonshire, UK</td>
			<td>G003709</td>
			<td>Lenses are rinsed with sterile PBS and stored in polypropylene boxes.</td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">HRA/Spectralis confocal scanning laser ophthalmoscope and Eye Explorer software</td>
			<td>Heidelberg Engineering GmbH, Carlsbad, CA</td>
			<td>Version 1.7.1.0</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">PowerPoint</td>
			<td>Microsoft, Redmond, WA</td>
			<td>Version 14.4.3</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">Adobe Photoshop</td>
			<td>Adobe, San Jose, CA</td>
			<td>Version CS3</td>
			<td></td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">FluoRender</td>
			<td>Scientific Computing and Imaging Institute, University of Utah</td>
			<td>Version 2.13</td>
			<td>Freeware. http://www.sci.utah.edu/software/13-software/127-fluorender.html</td>
		</tr>
		<tr height="20">
			<td height="20" style="height:20px;">NIS-Elements C</td>
			<td>Nikon, Melville, NY</td>
			<td>Version 4.30.01</td>
			<td></td>
		</tr>
	</tbody>
</table>

in vivo dynamics of retinal microglial activation during neurodegeneration: confocal ophthalmoscopic imaging and cell morphometry in mouse glaucoma

小胶质细胞，这是CNS驻地神经免疫细胞，改变其形态和大小响应中枢神经系统损伤，切换到激活状态具有不同的功能和基因表达谱。在健康，损伤和疾病胶质细胞活化的作用仍然不完全是由于他们的动态和复杂的调节反应的变化在他们的微环境的理解。因此，它是对非侵入性地监控关键和分析在完整生物体随时间的变化小胶质细胞活化。在体内胶质细胞活化的研究已经被推迟了技术限制，以跟踪小胶质细胞的行为没有改变中枢神经系统环境。这已经在慢性神经变性，在那里长期变化必须跟踪是特别具有挑战性的。视网膜，中枢神经系统器官适合于非侵入性的实时成像，提供了强大的系统，以可视化和在慢性病症表征小胶质细胞活化的动力学。 在体内成像的视网膜小胶质细胞，使用共聚焦检眼镜（CSLO）和CX3CR1 GFP / +报告小鼠，以可视化的小胶质细胞与细胞的分辨率的方法。此外，我们描述的方法来量化细胞活化和密度大细胞亚群每月改变（每视网膜200-300个细胞）。我们确认使用常染色体区域的作为用于在视网膜小胶质细胞活化的活跟踪一个有用的度量通过施加在体内图像的自动阈值基于形态测定分析。我们使用这些实时图像采集和分析的策略中的视网膜神经变性的慢性青光眼的小鼠模型的早期阶段，以监测小胶质细胞活化和小神经胶质细胞的动态变化。这种方法应该是有用，调查小胶质细胞在慢性中枢神经系统疾病，影响视网膜和视神经的神经元和轴突下降的贡献。

我们最近在体内的研究中使用这些实时图像采集和分析方法，以可视化，并在慢性青光眼和他们的关系的早期阶段跟踪动力学和视盘和视网膜小胶质细胞的变化模式来晚了神经退行性疾病59。在这里，我们示出了CSLO图像采集协议跨越大面积在个别年轻杂CX3CR1-GFP的DBA / 2J视网膜中央视网膜（ 图5）的可视化的小神经胶质细胞。基于高元分辨率，我们应用实时图像阈值和形?...

Watch this Scientific Journal Video about In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma at JoVE.co

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

小胶质细胞活化和小神经胶质细胞是关键应对慢性神经退行性病变。这里，我们提出在体内 ，视网膜CX3CR1-GFP +胶质细胞共聚焦检眼镜的长期可视化方法，以及用于阈和形态分析，以确定和量化它们的活化。我们监测期间与年龄有关的青光眼的早期阶段小胶质细胞的变化。

视网膜胶质细胞活化的体内动力学在神经退行性疾病：共聚焦成像眼底及细胞形态计量小鼠青光眼

Microglia, which are CNS-resident neuroimmune cells, transform their morphology and size in response to CNS damage, switching to an activated state with ...

in-vivo-dynamics-retinal-microglial-activation-during

Research

JoVE Journal

Medicine

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

10.5K 次观看.  University of Utah. 小胶质细胞活化和小神经胶质细胞是关键应对慢性神经退行性病变。这里，我们提出在体内 ，视网膜CX3CR1-GFP +胶质细胞共聚焦检眼镜的长期可视化方法，以及用于阈和形态分析，以确定和量化它们的活化。我们监测期间与年龄有关的青光眼的早期阶段小胶质细胞的变化。 

视频: In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma

Loco-regional invasion of head and neck cancer is linked to metastatic risk and presents a difficult challenge in designing and implementing patient management strategies. Orthotopic mouse models of oral cancer have been developed to facilitate the study of factors that impact invasion and serve as model system for evaluating anti-tumor therapeutics. In these systems, visualization of disseminated tumor cells within oral cavity tissues has typically been conducted by either conventional histology or with in vivo bioluminescent methods. A primary drawback of these techniques is the inherent inability to accurately visualize and quantify early tumor cell invasion arising from the primary site in three dimensions. Here we describe a protocol that combines an established model for squamous cell carcinoma of the tongue (SCOT) with two-photon imaging to allow multi-vectorial visualization of lingual tumor spread. The OSC-19 head and neck tumor cell line was stably engineered to express the F-actin binding peptide LifeAct fused to the mCherry fluorescent protein (LifeAct-mCherry). Fox1nu/nu mice injected with these cells reliably form tumors that allow the tongue to be visualized by ex-vivo application of two-photon microscopy. This technique allows for the orthotopic visualization of the tumor mass and locally invading cells in excised tongues without disruption of the regional tumor microenvironment. In addition, this system allows for the quantification of tumor cell invasion by calculating distances that invaded cells move from the primary tumor site. Overall this procedure provides an enhanced model system for analyzing factors that contribute to SCOT invasion and therapeutic treatments tailored to prevent local invasion and distant metastatic spread. This method also has the potential to be ultimately combined with other imaging modalities in an in vivo setting.

A comprehensive overview of the techniques involved in generating a mouse model of oral cancer and quantitative monitoring of tumor invasion within the tongue through multi-photon microscopy of labeled cells is presented. This system can serve as a useful platform for the molecular assessment and drug efficacy of anti-invasive compounds.

多光子成像在口腔鳞状细胞癌原位小鼠模型的肿瘤细胞的侵袭

Loco-regional invasion of head and neck cancer is linked to metastatic risk and presents a difficult challenge in designing and implementing patient ...

科研

医学

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

It is well recognized that tumor hypoxia plays an important role in promoting malignant progression and affecting therapeutic response negatively. There is little knowledge about in situ, in vivo, tumor hypoxia during intracranial development of malignant brain tumors because of lack of efficient means to monitor it in these deep-seated orthotopic tumors. Bioluminescence imaging (BLI), based on the detection of light emitted by living cells expressing a luciferase gene, has been rapidly adopted for cancer research, in particular, to evaluate tumor growth or tumor size changes in response to treatment in preclinical animal studies. Moreover, by expressing a reporter gene under the control of a promoter sequence, the specific gene expression can be monitored non-invasively by BLI. Under hypoxic stress, signaling responses are mediated mainly via the hypoxia inducible factor-1&alpha; (HIF-1&alpha;) to drive transcription of various genes. Therefore, we have used a HIF-1&alpha; reporter construct, 5HRE-ODD-luc, stably transfected into human breast cancer MDA-MB231 cells (MDA-MB231/5HRE-ODD-luc). In vitro HIF-1&alpha; bioluminescence assay is performed by incubating the transfected cells in a hypoxic chamber (0.1% O2) for 24 hr before BLI, while the cells in normoxia (21% O2) serve as a control. Significantly higher photon flux observed for the cells under hypoxia suggests an increased HIF-1&alpha; binding to its promoter (HRE elements), as compared to those in normoxia. Cells are injected directly into the mouse brain to establish a breast cancer brain metastasis model. In vivo bioluminescence imaging of tumor hypoxia dynamics is initiated 2 wks after implantation and repeated once a week. BLI reveals increasing light signals from the brain as the tumor progresses, indicating increased intracranial tumor hypoxia. Histological and immunohistochemical studies are used to confirm the in vivo imaging results. Here, we will introduce approaches of in vitro HIF-1&alpha; bioluminescence assay, surgical establishment of a breast cancer brain metastasis in a nude mouse and application of in vivo bioluminescence imaging to monitor intracranial tumor hypoxia.

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

Bioluminescence imaging of hypoxia inducible factor-1&alpha; activity is applied to monitor intracranial tumor hypoxia development in a breast cancer brain metastasis mouse model.

在小鼠模型体内生物发光成像乳腺癌脑转移的肿瘤乏氧动力学

It is well recognized that tumor hypoxia plays an important role in promoting malignant progression and affecting therapeutic response negatively. There ...

In vivo Imaging of Tumor Angiogenesis using Fluorescence Confocal Videomicroscopy

Fibered confocal fluorescence in vivo imaging with a fiber optic bundle uses the same principle as fluorescent confocal microscopy. It can excite fluorescent in situ elements through the optical fibers, and then record some of the emitted photons, via the same optical fibers. The light source is a laser that sends the exciting light through an element within the fiber bundle and as it scans over the sample, recreates an image pixel by pixel. As this scan is very fast, by combining it with dedicated image processing software, images in real time with a frequency of 12 frames/sec can be obtained.
We developed a technique to quantitatively characterize capillary morphology and function, using a confocal fluorescence videomicroscopy device. The first step in our experiment was to record 5 sec movies in the four quadrants of the tumor to visualize the capillary network. All movies were processed using software (ImageCell, Mauna Kea Technology, Paris France) that performs an automated segmentation of vessels around a chosen diameter (10 &mu;m in our case). Thus, we could quantify the 'functional capillary density', which is the ratio between the total vessel area and the total area of the image. This parameter was a surrogate marker for microvascular density, usually measured using pathology tools.
The second step was to record movies of the tumor over 20 min to quantify leakage of the macromolecular contrast agent through the capillary wall into the interstitium. By measuring the ratio of signal intensity in the interstitium over that in the vessels, an 'index leakage' was obtained, acting as a surrogate marker for capillary permeability.

In vivo Imaging of Tumor Angiogenesis using Fluorescence Confocal Videomicroscopy

In this paper, we present a method to analyze tumor microvessels in vivo using dynamic contrast-enhanced fluorescence videomicroscopy. Two quantitative parameters were acquired: functional capillary density reflecting the vascularity of the tumor, and index leakage reflecting the leakiness of the endothelial wall.

在肿瘤血管生成中使用荧光共聚焦电视显微镜活体成像

Fibered confocal fluorescence in vivo imaging with a fiber optic bundle uses the same principle as fluorescent confocal microscopy. It can excite ...

In vivo 19F MRI for Cell Tracking

In vivo 19F MRI allows quantitative cell tracking without the use of ionizing radiation. It is a noninvasive technique that can be applied to humans. Here, we describe a general protocol for cell labeling, imaging, and image processing. The technique is applicable to various cell types and animal models, although here we focus on a typical mouse model for tracking murine immune cells. The most important issues for cell labeling are described, as these are relevant to all models. Similarly, key imaging parameters are listed, although the details will vary depending on the MRI system and the individual setup. Finally, we include an image processing protocol for quantification. Variations for this, and other parts of the protocol, are assessed in the Discussion section. Based on the detailed procedure described here, the user will need to adapt the protocol for each specific cell type, cell label, animal model, and imaging setup. Note that the protocol can also be adapted for human use, as long as clinical restrictions are met.

In vivo 19F MRI for Cell Tracking

We describe a general protocol for in vivo cell tracking using MRI in a mouse model with ex vivo labeled cells. A typical protocol for cell labeling, image acquisition processing and quantification is included.

在体内 19女性 MRI对细胞跟踪

In vivo 19F MRI allows quantitative cell tracking without the use of ionizing radiation. It is a noninvasive technique that can be applied to humans. ...

Sequential In vivo Imaging of Osteogenic Stem/Progenitor Cells During Fracture Repair

Bone turns over continuously and is highly regenerative following injury. Osteogenic stem/progenitor cells have long been hypothesized to exist, but in vivo demonstration of such cells has only recently been attained. Here, in vivo imaging techniques to investigate the role of endogenous osteogenic stem/progenitor cells (OSPCs) and their progeny in bone repair are provided. Using osteo-lineage cell tracing models and intravital imaging of induced microfractures in calvarial bone, OSPCs can be directly observed during the first few days after injury, in which critical events in the early repair process occur. Injury sites can be sequentially imaged revealing that OSPCs relocate to the injury, increase in number and differentiate into bone forming osteoblasts. These methods offer a means of investigating the role of stem cell-intrinsic and extrinsic molecular regulators for bone regeneration and repair.

Sequential In vivo Imaging of Osteogenic Stem/Progenitor Cells During Fracture Repair

Quantitative measurement of bone progenitor function in fracture healing requires high resolution serial imaging technology. Here, protocols are provided for using intravital microscopy and osteo-lineage tracking to sequentially image and quantify the migration, proliferation and differentiation of endogenous osteogenic stem/progenitor cells in the process of repairing bone fracture.

顺序<em&gt;在体内</em&gt;成骨干/祖细胞在骨折修复的影像学

Bone turns over continuously and is highly regenerative following injury. Osteogenic stem/progenitor cells have long been hypothesized to exist, but in ...

Intrauterine Telemetry to Measure Mouse Contractile Pressure In Vivo

A complex integration of molecular and electrical signals is needed to transform a quiescent uterus into a contractile organ at the end of pregnancy. Despite the discovery of key regulators of uterine contractility, this process is still not fully understood. Transgenic mice provide an ideal model in which to study parturition. Previously, the only method to study uterine contractility in the mouse was ex vivo isometric tension recordings, which are suboptimal for several reasons. The uterus must be removed from its physiological environment, a limited time course of investigation is possible, and the mice must be sacrificed. The recent development of radiometric telemetry has allowed for longitudinal, real-time measurements of in vivo intrauterine pressure in mice. Here, the implantation of an intrauterine telemeter to measure pressure changes in the mouse uterus from mid-pregnancy until delivery is described. By comparing differences in pressures between wild type and transgenic mice, the physiological impact of a gene of interest can be elucidated. This technique should expedite the development of therapeutics used to treat myometrial disorders during pregnancy, including preterm labor.

Intrauterine Telemetry to Measure Mouse Contractile Pressure In Vivo

This manuscript provides a protocol for implanting telemeters in the mouse for the purpose of measuring intrauterine pressures during pregnancy.

宫内遥测来衡量鼠标收缩压力<em&gt;在体内</em

A complex integration of molecular and electrical signals is needed to transform a quiescent uterus into a contractile organ at the end of pregnancy. ...

Rose Bengal Photothrombosis by Confocal Optical Imaging In Vivo: A Model of Single Vessel Stroke

In vivo imaging techniques have increased in utilization due to recent advances in imaging dyes and optical technologies, allowing for the ability to image cellular events in an intact animal. Additionally, the ability to induce physiological disease states such as stroke in vivo increases its utility. The technique described herein allows for physiological assessment of cellular responses within the CNS following a stroke and can be adapted for other pathological conditions being studied. The technique presented uses laser excitation of the photosensitive dye Rose Bengal in vivo to induce a focal ischemic event in a single blood vessel. 
The video protocol demonstrates the preparation of a thin-skulled cranial window over the somatosensory cortex in a mouse for the induction of a Rose Bengal photothrombotic event keeping injury to the underlying dura matter and brain at a minimum. Surgical preparation is initially performed under a dissecting microscope with a custom-made surgical/imaging platform, which is then transferred to a confocal microscope equipped with an inverted objective adaptor. Representative images acquired utilizing this protocol are presented as well as time-lapse sequences of stroke induction. This technique is powerful in that the same area can be imaged repeatedly on subsequent days facilitating longitudinal in vivo studies of pathological processes following stroke.

Rose Bengal Photothrombosis by Confocal Optical Imaging In Vivo:  A Model of Single Vessel Stroke

Here, we describe a semi-invasive optical microscopy approach for the induction of a Rose Bengal photothrombotic clot in the somatosensory cortex of a mouse in vivo. The technical aspects of the imaging procedure are described from induction of a photothrombotic event to application and data collection.

玫瑰红Photothrombosis共聚焦光学成像<em&gt;在体内</em&gt;：单支脑卒中模型

In vivo imaging techniques have increased in utilization due to recent advances in imaging dyes and optical technologies, allowing for the ability to ...

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma is a disease of the central nervous system affecting retinal ganglion cells (RGCs). RGC axons making up the optic nerve carry visual input to the brain for visual perception. Damage to RGCs and their axons leads to vision loss and/or blindness. Although the specific cause of glaucoma is unknown, the primary risk factor for the disease is an elevated intraocular pressure. Glaucoma-inducing procedures in animal models are a valuable tool to researchers studying the mechanism of RGC death. Such information can lead to the development of effective neuroprotective treatments that could aid in the prevention of vision loss. The protocol in this paper describes a method of inducing glaucoma - like conditions in an in vivo rat model where 50 &#181;l of 2 M hypertonic saline is injected into the episcleral venous plexus. Blanching of the vessels indicates successful injection. This procedure causes loss of RGCs to simulate glaucoma. One month following injection, animals are sacrificed and eyes are removed. Next, the cornea, lens, and vitreous are removed to make an eyecup. The retina is then peeled from the back of the eye and pinned onto sylgard dishes using cactus needles. At this point, neurons in the retina can be stained for analysis. Results from this lab show that approximately 25% of RGCs are lost within one month of the procedure when compared to internal controls. This procedure allows for quantitative analysis of retinal ganglion cell death in an in vivo rat glaucoma model.

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma is characterized by damage to retinal ganglion cells. Inducing glaucoma in animal models can provide insight into the study of this disease. Here, we outline a procedure that induces loss of RGCs in an in vivo rat model and demonstrates the preparation of whole-mount retinas for analysis.

青光眼诱导在程序<em&gt;在体内</em&gt;大鼠模型和全安装视网膜准备

Glaucoma is a disease of the central nervous system affecting retinal ganglion cells (RGCs). RGC axons making up the optic nerve carry visual input to the ...

Depletion of Mouse Cells from Human Tumor Xenografts Significantly Improves Downstream Analysis of Target Cells

The use of in vitro cell line models for cancer research has been a useful tool. However, it has been shown that these models fail to reliably mimic patient tumors in different assays1. Human tumor xenografts represent the gold standard with respect to tumor biology, drug discovery, and metastasis research 2-4. Tumor xenografts can be derived from different types of material like tumor cell lines, tumor tissue from primary patient tumors4 or serially transplanted tumors. When propagated in vivo, xenografted tissue is infiltrated and vascularized by cells of mouse origin. Multiple factors such as the tumor entity, the origin of xenografted material, growth rate and region of transplantation influence the composition and the amount of mouse cells present in tumor xenografts. However, even when these factors are kept constant, the degree of mouse cell contamination is highly variable.
Contaminating mouse cells significantly impair downstream analyses of human tumor xenografts. As mouse fibroblasts show high plating efficacies and proliferation rates, they tend to overgrow cultures of human tumor cells, especially slowly proliferating subpopulations. Mouse cell derived DNA, mRNA, and protein components can bias downstream gene expression analysis, next-generation sequencing, as well as proteome analysis 5. To overcome these limitations, we have developed a fast and easy method to isolate untouched human tumor cells from xenografted tumor tissue. This procedure is based on the comprehensive depletion of cells of mouse origin by combining automated tissue dissociation with the benchtop tissue dissociator and magnetic cell sorting. Here, we demonstrate that human target cells can be can be obtained with purities higher than 96% within less than 20 min independent of the tumor type.

Human tumor xenografts are vascularized and infiltrated by cells of mouse origin during the growth phase in vivo. To circumvent the bias caused by these contaminating cells during downstream analysis, we developed a method allowing for comprehensive depletion of all mouse cells by magnetic cell sorting.

从人类肿瘤异种移植的小鼠细胞的消耗显着改善靶细胞下游分析

The use of in vitro cell line models for cancer research has been a useful tool. However, it has been shown that these models fail to reliably mimic ...

Fluorescent Dye Labeling of Erythrocytes and Leukocytes for Studying the Flow Dynamics in Mouse Retinal Circulation

The retinal and choroidal blood flow dynamics may provide insight into the pathophysiology and sequelae of various ocular diseases, such as glaucoma, diabetic retinopathy, age-related macular degeneration (AMD) and other ocular inflammatory conditions. It may also help to monitor the therapeutic responses in the eye. The proper labeling of the blood cells, coupled with live-cell imaging of the labeled cells, allows for the investigation of the flow dynamics in the retinal and choroidal circulation. Here, we describe the standardized protocols of 1.5% indocyanine green (ICG) and 1% sodium fluorescein labeling of mice erythrocytes and leukocytes, respectively. Scanning laser ophthalmoscopy (SLO) was applied to visualize the labeled cells in the retinal circulation of C57BL/6J mice (wild type). Both methods demonstrated distinct fluorescently labeled cells in the mouse retinal circulation. These labeling methods can have wider applications in various ocular disease models.

Live-cell imaging of the labeled blood cells in ocular circulation can provide information about inflammation and ischemia in diabetic retinopathy and age-related macular degeneration. A protocol to label blood cells and image the labeled cells in the retinal circulation is described.

用于研究小鼠视网膜循环中流动动力学的红细胞和白细胞的荧光染料标记

The retinal and choroidal blood flow dynamics may provide insight into the pathophysiology and sequelae of various ocular diseases, such as glaucoma, ...